DARATUMUMAB for Plasma cell myeloma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 789 adverse event reports in the FDA FAERS database where DARATUMUMAB was used for Plasma cell myeloma refractory.

Most Reported Side Effects for DARATUMUMAB

Side Effect	Reports	%	Deaths	Hosp.
Plasma cell myeloma	2,980	10.9%	680	439
Infusion related reaction	2,557	9.3%	241	629
Off label use	2,494	9.1%	425	783
Pneumonia	1,450	5.3%	336	1,018
Neutropenia	1,351	4.9%	192	371
Drug ineffective	1,110	4.1%	240	217
Thrombocytopenia	1,089	4.0%	199	374
Death	1,088	4.0%	1,088	200
Pyrexia	1,032	3.8%	140	592
Dyspnoea	996	3.6%	98	404
Neuropathy peripheral	955	3.5%	45	116
Anaemia	925	3.4%	171	380
Diarrhoea	916	3.3%	130	414
Fatigue	796	2.9%	73	207
Intentional product use issue	711	2.6%	56	108